1572 related articles for article (PubMed ID: 17460447)
21. Metastatic HPV-related cervical adenocarcinomas presenting with thromboembolic events (Trousseau Syndrome): clinicopathologic characteristics of 2 cases.
Veras E; Srodon M; Neijstrom ES; Ronnett BM
Int J Gynecol Pathol; 2009 Mar; 28(2):134-9. PubMed ID: 19188822
[TBL] [Abstract][Full Text] [Related]
22. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
Loy TS; Calaluce RD; Keeney GL
Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
[TBL] [Abstract][Full Text] [Related]
24. Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.
Heinzelmann-Schwarz VA; Scolyer RA; Scurry JP; Smith AN; Gardiner-Garden M; Biankin AV; Baron-Hay S; Scott C; Ward RL; Fink D; Hacker NF; Sutherland RL; O'Brien PM
J Clin Pathol; 2007 Jun; 60(6):622-6. PubMed ID: 16822880
[TBL] [Abstract][Full Text] [Related]
25. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
26. P16 as a molecular biomarker of cervical adenocarcinoma.
Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
[TBL] [Abstract][Full Text] [Related]
27. The endocervical origin of HPV-positive mucinous/endometrioid ovarian tumors remains unproven.
Reichert RA
Int J Gynecol Pathol; 2010 May; 29(3):298-300; author reply 300-1; discussion 300-2. PubMed ID: 20407334
[No Abstract] [Full Text] [Related]
28. DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas.
Saegusa M; Okayasu I
Br J Cancer; 1999 Apr; 80(1-2):51-8. PubMed ID: 10389977
[TBL] [Abstract][Full Text] [Related]
29. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
30. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
[TBL] [Abstract][Full Text] [Related]
31. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
32. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
34. Biomarker-assisted diagnosis of ovarian, cervical and pulmonary small cell carcinomas: the role of TTF-1, WT-1 and HPV analysis.
Carlson JW; Nucci MR; Brodsky J; Crum CP; Hirsch MS
Histopathology; 2007 Sep; 51(3):305-12. PubMed ID: 17727473
[TBL] [Abstract][Full Text] [Related]
35. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
36. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
[TBL] [Abstract][Full Text] [Related]
37. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
38. Mammaglobin expression in gynecologic adenocarcinomas.
Hagemann IS; Pfeifer JD; Cao D
Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
[TBL] [Abstract][Full Text] [Related]
39. Synchronous ovarian endometrioid adenocarcinoma and endocervical mucinous adenocarcinoma.
Huang YD; Hung YC; Yeh LS; Chiang IP; Zeng GC; Chang WC
Taiwan J Obstet Gynecol; 2006 Sep; 45(3):264-7. PubMed ID: 17175478
[TBL] [Abstract][Full Text] [Related]
40. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
